Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Kalim Mir is managing 1 pending office action in the Biotechnology & Pharmaceuticals technology area. The action is under the review of 1 distinct examiner, MUMMERT, STEPHANIE KANE, in 1 distinct art unit. This represents the entirety of the company's current pending office action activity. This centralized structure means that the company's current patent office engagement is restricted to a single administrative track.
The busiest examiner for the portfolio is MUMMERT, STEPHANIE KANE, who is responsible for 1 pending office action. Because there is only 1 distinct examiner and 1 distinct art unit involved, the prosecution strategy does not require coordination across multiple divisions. This concentration suggests a patent portfolio where all active matters are consolidated under a single point of review at the patent office. The presence of 1 pending office action indicates a prosecution pipeline that is currently limited to a single matter. This allows for a response strategy tailored to the specific requirements of the 1 distinct examiner.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §102 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MUMMERT, STEPHANIE KANE | 1 | 61.4% | +21.2% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18554150 | SYSTEMS, METHODS, AND COMPOSITIONS FOR DETECTING EPIGENETIC MODIFICATIONS OF NUCLEIC ACIDS | MUMMERT, STEPHANIE KANE | — |
| Art Unit | Apps |
|---|---|
| 1681 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18554150 | SYSTEMS, METHODS, AND COMPOSITIONS FOR DETECTING EPIGENETIC MODIFICATIONS OF NUCLEIC ACIDS | MUMMERT, STEPHANIE KANE | 1681 | §102 | Non-Final OA | — | Pending | Oct 05, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialKalim Mir has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Stephanie Kane Mummert has the most, with 1 of Kalim Mir's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
